QQQ   346.99 (-1.79%)
AAPL   160.08 (-0.95%)
MSFT   292.01 (-1.47%)
FB   303.43 (-1.71%)
GOOGL   2,563.26 (-2.02%)
AMZN   2,807.43 (-2.89%)
TSLA   926.94 (-0.33%)
NVDA   225.54 (-3.50%)
BABA   119.21 (-0.96%)
NIO   23.99 (-3.54%)
AMD   112.25 (-3.67%)
CGC   7.30 (-1.35%)
MU   81.47 (-1.78%)
GE   90.74 (-6.37%)
T   26.40 (+0.23%)
F   19.96 (-2.11%)
DIS   136.09 (-1.00%)
AMC   16.39 (-1.50%)
PFE   52.58 (+2.02%)
ACB   4.18 (-3.24%)
BA   203.00 (-0.59%)
QQQ   346.99 (-1.79%)
AAPL   160.08 (-0.95%)
MSFT   292.01 (-1.47%)
FB   303.43 (-1.71%)
GOOGL   2,563.26 (-2.02%)
AMZN   2,807.43 (-2.89%)
TSLA   926.94 (-0.33%)
NVDA   225.54 (-3.50%)
BABA   119.21 (-0.96%)
NIO   23.99 (-3.54%)
AMD   112.25 (-3.67%)
CGC   7.30 (-1.35%)
MU   81.47 (-1.78%)
GE   90.74 (-6.37%)
T   26.40 (+0.23%)
F   19.96 (-2.11%)
DIS   136.09 (-1.00%)
AMC   16.39 (-1.50%)
PFE   52.58 (+2.02%)
ACB   4.18 (-3.24%)
BA   203.00 (-0.59%)
QQQ   346.99 (-1.79%)
AAPL   160.08 (-0.95%)
MSFT   292.01 (-1.47%)
FB   303.43 (-1.71%)
GOOGL   2,563.26 (-2.02%)
AMZN   2,807.43 (-2.89%)
TSLA   926.94 (-0.33%)
NVDA   225.54 (-3.50%)
BABA   119.21 (-0.96%)
NIO   23.99 (-3.54%)
AMD   112.25 (-3.67%)
CGC   7.30 (-1.35%)
MU   81.47 (-1.78%)
GE   90.74 (-6.37%)
T   26.40 (+0.23%)
F   19.96 (-2.11%)
DIS   136.09 (-1.00%)
AMC   16.39 (-1.50%)
PFE   52.58 (+2.02%)
ACB   4.18 (-3.24%)
BA   203.00 (-0.59%)
QQQ   346.99 (-1.79%)
AAPL   160.08 (-0.95%)
MSFT   292.01 (-1.47%)
FB   303.43 (-1.71%)
GOOGL   2,563.26 (-2.02%)
AMZN   2,807.43 (-2.89%)
TSLA   926.94 (-0.33%)
NVDA   225.54 (-3.50%)
BABA   119.21 (-0.96%)
NIO   23.99 (-3.54%)
AMD   112.25 (-3.67%)
CGC   7.30 (-1.35%)
MU   81.47 (-1.78%)
GE   90.74 (-6.37%)
T   26.40 (+0.23%)
F   19.96 (-2.11%)
DIS   136.09 (-1.00%)
AMC   16.39 (-1.50%)
PFE   52.58 (+2.02%)
ACB   4.18 (-3.24%)
BA   203.00 (-0.59%)
NASDAQ:ADMA

ADMA Biologics Insider Trades

$1.40
+0.02 (+1.08%)
(As of 01/25/2022 01:52 PM ET)
Add
Compare
Today's Range
$1.38
$1.41
50-Day Range
$1.20
$1.55
52-Week Range
$1.01
$3.11
Volume
45,254 shs
Average Volume
1.52 million shs
Market Capitalization
$275.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.24

ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.70%

Number Of
Insiders Buying
(Last 12 Months)
3

Amount Of
Insider Buying
(Last 12 Months)
$380 K

Number Of
Insiders Selling
(Last 12 Months)
1

Amount Of
Insider Selling
(Last 12 Months)
$3.02 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ADMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADMA Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


ADMA Biologics (NASDAQ ADMA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2021Adam S GrossmanCEOBuy250,000$1.00$250,000.00  
10/25/2021Brian LenzCFOBuy30,000$1.00$30,000.00  
10/25/2021Young KwonDirectorBuy100,000$1.00$100,000.00  
9/29/2021Perceptive Advisors LlcMajor ShareholderSell82,505$1.16$95,705.80  
9/27/2021Perceptive Advisors LlcMajor ShareholderSell250,000$1.23$307,500.00  
9/23/2021Perceptive Advisors LlcMajor ShareholderSell780,000$1.27$990,600.00  
8/19/2021Perceptive Advisors LlcMajor ShareholderSell350,352$1.24$434,436.48  
8/17/2021Perceptive Advisors LlcMajor ShareholderSell879,092$1.35$1,186,774.20  
9/10/2020Jerrold B. GrossmanDirectorBuy5,000$2.22$11,100.00  
9/10/2020Jerrold B. GrossmanDirectorBuy5,000$2.22$11,100.00  
9/8/2020James MondCMOBuy4,000$2.20$8,800.00  
8/21/2020Jerrold B. GrossmanDirectorBuy5,300$2.56$13,568.00  
8/12/2020Jerrold B. GrossmanDirectorBuy10,200$2.89$29,478.00  
8/11/2020Brian LenzCFOBuy4,000$2.97$11,880.00  
8/10/2020Adam S. GrossmanCEOBuy5,000$3.06$15,300.00  
8/10/2020James MondCMOBuy7,000$2.88$20,160.00  
3/19/2020Perceptive Advisors LlcMajor ShareholderBuy500,000$2.10$1,050,000.00  
2/11/2020Adam S GrossmanCEOBuy28,571$3.50$99,998.5066,098  
2/11/2020Brian LenzCFOBuy7,142$3.50$24,997.0032,142  
2/11/2020James MondCMOBuy4,285$3.50$14,997.5022,174  
2/11/2020Lawrence P GuiheenDirectorBuy20,000$3.50$70,000.0070,000  
2/11/2020Perceptive Advisors LlcMajor ShareholderBuy4,563,700$3.50$15,972,950.00  
6/6/2019Biotest Divestiture TrustMajor ShareholderSell5,813,954$3.75$21,802,327.504,295,580  
5/21/2019Life Sciences Maste PerceptiveMajor ShareholderBuy4,000,000$4.00$16,000,000.00  
5/17/2019Adam S GrossmanInsiderBuy30,000$4.00$120,000.0037,527  
5/17/2019Brian LenzCFOBuy5,000$4.00$20,000.0025,000  
5/17/2019James MondEVPBuy4,500$4.00$18,000.0017,889  
5/17/2019Lawrence P GuiheenDirectorBuy25,000$4.00$100,000.0050,000  
6/8/2018Adam S GrossmanCEOBuy52,301$4.78$249,998.7832,527  
6/8/2018Brian LenzCFOBuy5,000$4.78$23,900.0020,000  
6/8/2018Jerrold B GrossmanDirectorBuy20,921$4.78$100,002.3898,007  
11/9/2017Adam S GrossmanInsiderBuy485,000$2.15$1,042,750.00  
11/9/2017Brian LenzCFOBuy6,500$2.15$13,975.0015,000  
11/9/2017Eric I RichmanDirectorBuy25,000$2.15$53,750.0031,300  
11/9/2017James MondCMOBuy10,000$2.15$21,500.0013,389  
5/3/2016Adam S GrossmanCEOBuy200,000$6.50$1,300,000.00  
5/3/2016Brian LenzCFOBuy2,500$6.50$16,250.008,500  
5/3/2016James MondCMOBuy770$6.50$5,005.003,389  
5/3/2016Jerrold B GrossmanDirectorBuy45,769$6.50$297,498.50  
12/8/2015Adam S. GrossmanCEOBuy500$9.00$4,500.00637,268  
12/7/2015Jerrold B GrossmanDirectorBuy500$9.01$4,505.0056,558  
12/2/2015Adam S GrossmanCEOBuy2,250$9.15$20,587.50636,768  
12/2/2015Brian LenzCFOBuy1,000$9.15$9,150.006,000  
12/2/2015Jerrold B GrossmanDirectorBuy6,000$9.16$54,960.0056,058  
12/1/2015Adam S GrossmanCEOBuy1,800$9.17$16,506.00  
11/25/2015Adam S GrossmanCEOBuy1,800$9.18$16,524.00  
11/20/2015Adam S GrossmanCEOBuy3,861$9.21$35,559.81628,418  
3/19/2015Adam S GrossmanCEOBuy2,000$8.50$17,000.00  
3/17/2015Adam S GrossmanCEOBuy5,500$7.98$43,890.00  
3/17/2015Jerrold B GrossmanDirectorBuy500$8.01$4,005.00  
3/16/2015Adam S GrossmanCEOBuy8,800$8.03$70,664.00  
3/16/2015James MondCMOBuy1,250$8.02$10,025.00  
3/16/2015Lawrence P GuiheenDirectorBuy1,000$7.96$7,960.00  
3/13/2015Eric I RichmanDirectorBuy3,500$7.88$27,580.00  
9/12/2014Adam S GrossmanCEOBuy4,300$9.57$41,151.00  
8/22/2014Adam S GrossmanCEOBuy1,000$9.50$9,500.00  
8/14/2014Adam S GrossmanCEOBuy2,100$9.77$20,517.00  
6/18/2014Adam S GrossmanCEOBuy1,875$9.59$17,981.25  
5/22/2014Adam S GrossmanCEOBuy4,226$8.15$34,441.90  
5/15/2014Adam S GrossmanCEOBuy13,400$7.50$100,500.00  
5/14/2014Brian LenzCFOBuy1,000$7.50$7,500.00  
5/14/2014James MondCMOBuy1,315$7.60$9,994.00  
12/10/2013Jerrold B GrossmanDirectorBuy3,650$7.30$26,645.00  
(Data available from 1/1/2013 forward)












ADMA Biologics (NASDAQ:ADMA) Insider Trade Frequently Asked Questions

Who is on ADMA Biologics's Insider Roster?

The list of insiders at ADMA Biologics includes Adam S Grossman, Biotest Divestiture Trust, Brian Lenz, James Mond, Jerrold B. Grossman, Lawrence P Guiheen, Life Sciences Maste Perceptive, Perceptive Advisors Llc, and Young Kwon.Learn more on ADMA's insiders

What percentage of ADMA Biologics stock is owned by insiders?

8.70% of ADMA Biologics stock is owned by insiders. Learn more on ADMA's insider holdings

Which ADMA Biologics insiders have been buying company stock?

The following insiders have purchased ADMA Biologics stock in the last 24 months: Adam S Grossman ($349,998.50), Brian Lenz ($66,877.00), James Mond ($43,957.50), Jerrold B. Grossman ($65,246.00), Lawrence P Guiheen ($70,000.00), Perceptive Advisors Llc ($17,022,950.00), and Young Kwon ($100,000.00).

How much insider buying is happening at ADMA Biologics?

Insiders have purchased a total of 5,549,198 ADMA Biologics shares in the last 24 months for a total of $17,734,329.00 bought.

Which ADMA Biologics insiders have been selling company stock?

The following insider sold ADMA Biologics stock in the last 24 months: Perceptive Advisors Llc ($3,015,016.48).

How much insider selling is happening at ADMA Biologics?

Insiders have sold a total of 2,341,949 ADMA Biologics shares in the last 24 months for a total of $3,015,016.48 sold.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.